On the spectral intermediate at 440 nm formed during mixed function substrate oxidation.
D000083:Acetanilides / Q000378:metabolism / Q000494:pharmacology; D000814:Aniline Compounds / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001463:Barbiturates / Q000378:metabolism / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003891:Desipramine / Q000378:metabolism / Q000494:pharmacology; D007099:Imipramine / Q000378:metabolism / Q000494:pharmacology; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D008797:Metyrapone / Q000378:metabolism / Q000494:pharmacology; D008862:Microsomes, Liver / Q000201:enzymology / Q000378:metabolism; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D009019:Morphinans / Q000378:metabolism / Q000494:pharmacology; D009243:NAD / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D010424:Pentobarbital / Q000378:metabolism / Q000494:pharmacology; D011335:Proadifen / Q000378:metabolism / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D051381:Rats; D013056:Spectrophotometry, Ultraviolet
D000083:Acetanilides; D000814:Aniline Compounds; D001463:Barbiturates; D009019:Morphinans; D009243:NAD; D009249:NADP; D003577:Cytochrome P-450 Enzyme System; D011335:Proadifen; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases; D010424:Pentobarbital; D007099:Imipramine; D003891:Desipramine; D008797:Metyrapone